nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—PLA2G4A—metabolic syndrome X	0.676	0.731	CbGaD
Fluocinolone Acetonide—NR3C1—metabolic syndrome X	0.248	0.269	CbGaD
Fluocinolone Acetonide—PLA2G4A—Acyl chain remodeling of CL—PLA2G6—metabolic syndrome X	0.00592	0.0995	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Acyl chain remodelling of PE—PLA2G6—metabolic syndrome X	0.00202	0.034	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Prostaglandin Synthesis and Regulation—HSD11B1—metabolic syndrome X	0.00198	0.0333	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Acyl chain remodelling of PC—PLA2G6—metabolic syndrome X	0.00189	0.0318	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Arachidonic acid metabolism—EPHX2—metabolic syndrome X	0.00174	0.0292	CbGpPWpGaD
Fluocinolone Acetonide—Taste metallic—Metformin—metabolic syndrome X	0.00165	0.187	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Nuclear Receptors—NR1H3—metabolic syndrome X	0.00159	0.0267	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet sensitization by LDL—APOB—metabolic syndrome X	0.00135	0.0227	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Nuclear Receptor transcription pathway—NR1H3—metabolic syndrome X	0.00125	0.0211	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Nuclear Receptors—NR1I3—metabolic syndrome X	0.00116	0.0195	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Nuclear Receptors—NR1I2—metabolic syndrome X	0.00106	0.0179	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—HDAC3—metabolic syndrome X	0.00103	0.0174	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Endothelins—COL3A1—metabolic syndrome X	0.00103	0.0173	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Signaling events mediated by HDAC Class II—HDAC3—metabolic syndrome X	0.00101	0.017	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—metabolic syndrome X	0.001	0.0168	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Transcription factor regulation in adipogenesis—SLC2A4—metabolic syndrome X	0.000945	0.0159	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Nuclear Receptor transcription pathway—NR1I3—metabolic syndrome X	0.000918	0.0154	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Nuclear Receptor transcription pathway—NR1I2—metabolic syndrome X	0.00084	0.0141	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—metabolic syndrome X	0.000807	0.0136	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Circadian Clock—HDAC3—metabolic syndrome X	0.000752	0.0126	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—FABP4—metabolic syndrome X	0.000752	0.0126	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—GCK—metabolic syndrome X	0.000698	0.0117	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Glycerophospholipid biosynthesis—PLA2G6—metabolic syndrome X	0.000691	0.0116	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Arachidonic acid metabolism—GGT1—metabolic syndrome X	0.000671	0.0113	CbGpPWpGaD
Fluocinolone Acetonide—Rhinorrhoea—Metformin—metabolic syndrome X	0.000647	0.0733	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—NR1I3—metabolic syndrome X	0.000628	0.0106	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—metabolic syndrome X	0.000622	0.0104	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—RETN—metabolic syndrome X	0.000617	0.0104	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—NR1H3—metabolic syndrome X	0.000593	0.00997	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Circadian Clock—NAMPT—metabolic syndrome X	0.000588	0.00988	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—FMO3—metabolic syndrome X	0.000556	0.00934	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Transcription factor regulation in adipogenesis—IRS1—metabolic syndrome X	0.000555	0.00932	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—metabolic syndrome X	0.000542	0.0091	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—SCD—metabolic syndrome X	0.000524	0.00881	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Circadian Clock—SREBF1—metabolic syndrome X	0.000524	0.0088	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Phospholipid metabolism—PLA2G6—metabolic syndrome X	0.000482	0.0081	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—metabolic syndrome X	0.00047	0.00789	CbGpPWpGaD
Fluocinolone Acetonide—Ear pain—Metformin—metabolic syndrome X	0.000446	0.0505	CcSEcCtD
Fluocinolone Acetonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—metabolic syndrome X	0.000432	0.00726	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Nuclear Receptors—PPARA—metabolic syndrome X	0.000423	0.00711	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—metabolic syndrome X	0.000415	0.00698	CbGpPWpGaD
Fluocinolone Acetonide—Fluticasone Propionate—PLA2G4A—metabolic syndrome X	0.000414	0.0583	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Platelet homeostasis—APOB—metabolic syndrome X	0.000399	0.0067	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of Androgen receptor activity—SIRT1—metabolic syndrome X	0.00039	0.00656	CbGpPWpGaD
Fluocinolone Acetonide—Hypoglycaemia—Metformin—metabolic syndrome X	0.00039	0.0441	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Metformin—metabolic syndrome X	0.000381	0.0431	CcSEcCtD
Fluocinolone Acetonide—Difluprednate—NR3C1—metabolic syndrome X	0.000367	0.0516	CrCbGaD
Fluocinolone Acetonide—Clocortolone—NR3C1—metabolic syndrome X	0.000356	0.05	CrCbGaD
Fluocinolone Acetonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—metabolic syndrome X	0.000353	0.00593	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Nuclear Receptors—PPARG—metabolic syndrome X	0.00035	0.00588	CbGpPWpGaD
Fluocinolone Acetonide—Nasopharyngitis—Metformin—metabolic syndrome X	0.00034	0.0385	CcSEcCtD
Fluocinolone Acetonide—Desonide—NR3C1—metabolic syndrome X	0.000336	0.0473	CrCbGaD
Fluocinolone Acetonide—Diflorasone—NR3C1—metabolic syndrome X	0.000336	0.0473	CrCbGaD
Fluocinolone Acetonide—NR3C1—Nuclear Receptor transcription pathway—PPARA—metabolic syndrome X	0.000334	0.00562	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—TRIB3—metabolic syndrome X	0.000329	0.00553	CbGpPWpGaD
Fluocinolone Acetonide—Influenza—Metformin—metabolic syndrome X	0.000329	0.0372	CcSEcCtD
Fluocinolone Acetonide—Desoximetasone—NR3C1—metabolic syndrome X	0.000328	0.0462	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—IRS1—metabolic syndrome X	0.000325	0.00547	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—metabolic syndrome X	0.000322	0.00541	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Circadian Clock—PPARA—metabolic syndrome X	0.000315	0.00529	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Arachidonic acid metabolism—PTGS2—metabolic syndrome X	0.000312	0.00525	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—INS—metabolic syndrome X	0.000312	0.00524	CbGpPWpGaD
Fluocinolone Acetonide—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.000306	0.0346	CcSEcCtD
Fluocinolone Acetonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—metabolic syndrome X	0.000305	0.00513	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—NAMPT—metabolic syndrome X	0.000295	0.00496	CbGpPWpGaD
Fluocinolone Acetonide—Infestation NOS—Metformin—metabolic syndrome X	0.000293	0.0332	CcSEcCtD
Fluocinolone Acetonide—Infestation—Metformin—metabolic syndrome X	0.000293	0.0332	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—metabolic syndrome X	0.000288	0.00483	CbGpPWpGaD
Fluocinolone Acetonide—Flurandrenolide—NR3C1—metabolic syndrome X	0.000287	0.0404	CrCbGaD
Fluocinolone Acetonide—Flumethasone Pivalate—NR3C1—metabolic syndrome X	0.000282	0.0397	CrCbGaD
Fluocinolone Acetonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—metabolic syndrome X	0.00028	0.0047	CbGpPWpGaD
Fluocinolone Acetonide—Halobetasol Propionate—NR3C1—metabolic syndrome X	0.000278	0.0391	CrCbGaD
Fluocinolone Acetonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—metabolic syndrome X	0.000276	0.00464	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—NOS3—metabolic syndrome X	0.000273	0.00459	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—HMGA1—metabolic syndrome X	0.000268	0.00451	CbGpPWpGaD
Fluocinolone Acetonide—Rhinitis—Metformin—metabolic syndrome X	0.000264	0.0299	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Adipogenesis—SREBF1—metabolic syndrome X	0.000263	0.00442	CbGpPWpGaD
Fluocinolone Acetonide—Connective tissue disorder—Metformin—metabolic syndrome X	0.000259	0.0293	CcSEcCtD
Fluocinolone Acetonide—Budesonide—NR3C1—metabolic syndrome X	0.000258	0.0364	CrCbGaD
Fluocinolone Acetonide—Amcinonide—NR3C1—metabolic syndrome X	0.000258	0.0364	CrCbGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—GCK—metabolic syndrome X	0.000254	0.00426	CbGpPWpGaD
Fluocinolone Acetonide—Fluticasone furoate—NR3C1—metabolic syndrome X	0.000253	0.0356	CrCbGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—AGT—metabolic syndrome X	0.000251	0.00422	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	0.000249	0.00418	CbGpPWpGaD
Fluocinolone Acetonide—Eye disorder—Metformin—metabolic syndrome X	0.000246	0.0279	CcSEcCtD
Fluocinolone Acetonide—Mometasone—NR3C1—metabolic syndrome X	0.000246	0.0346	CrCbGaD
Fluocinolone Acetonide—Rimexolone—NR3C1—metabolic syndrome X	0.000243	0.0342	CrCbGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—ADIPOQ—metabolic syndrome X	0.000242	0.00406	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet homeostasis—NOS3—metabolic syndrome X	0.000239	0.00402	CbGpPWpGaD
Fluocinolone Acetonide—Mediastinal disorder—Metformin—metabolic syndrome X	0.000237	0.0269	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Circadian Clock—SERPINE1—metabolic syndrome X	0.000234	0.00394	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—metabolic syndrome X	0.000232	0.0039	CbGpPWpGaD
Fluocinolone Acetonide—Erythema—Metformin—metabolic syndrome X	0.000229	0.0259	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Metformin—metabolic syndrome X	0.000229	0.0259	CcSEcCtD
Fluocinolone Acetonide—Beclomethasone—NR3C1—metabolic syndrome X	0.000229	0.0322	CrCbGaD
Fluocinolone Acetonide—Fluocinonide—NR3C1—metabolic syndrome X	0.000229	0.0322	CrCbGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—SLC2A4—metabolic syndrome X	0.000228	0.00384	CbGpPWpGaD
Fluocinolone Acetonide—Dysgeusia—Metformin—metabolic syndrome X	0.000224	0.0254	CcSEcCtD
Fluocinolone Acetonide—Alclometasone—NR3C1—metabolic syndrome X	0.000223	0.0313	CrCbGaD
Fluocinolone Acetonide—Clobetasol propionate—NR3C1—metabolic syndrome X	0.000217	0.0305	CrCbGaD
Fluocinolone Acetonide—Flunisolide—NR3C1—metabolic syndrome X	0.000217	0.0305	CrCbGaD
Fluocinolone Acetonide—Fludrocortisone—NR3C1—metabolic syndrome X	0.000217	0.0305	CrCbGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—NR1H3—metabolic syndrome X	0.000217	0.00364	CbGpPWpGaD
Fluocinolone Acetonide—Vision blurred—Metformin—metabolic syndrome X	0.000216	0.0245	CcSEcCtD
Fluocinolone Acetonide—Paramethasone—NR3C1—metabolic syndrome X	0.000214	0.0301	CrCbGaD
Fluocinolone Acetonide—Fluorometholone—NR3C1—metabolic syndrome X	0.000209	0.0294	CrCbGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CCL2—metabolic syndrome X	0.000207	0.00348	CbGpPWpGaD
Fluocinolone Acetonide—Methylprednisolone—NR3C1—metabolic syndrome X	0.000202	0.0284	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	0.000199	0.00334	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—SIRT1—metabolic syndrome X	0.000198	0.00332	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	0.000188	0.00317	CbGpPWpGaD
Fluocinolone Acetonide—Oedema—Metformin—metabolic syndrome X	0.000187	0.0212	CcSEcCtD
Fluocinolone Acetonide—Infection—Metformin—metabolic syndrome X	0.000186	0.021	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Metformin—metabolic syndrome X	0.000183	0.0208	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Adipogenesis—LPL—metabolic syndrome X	0.000179	0.00301	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—IGF2—metabolic syndrome X	0.000179	0.003	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—metabolic syndrome X	0.000172	0.00289	CbGpPWpGaD
Fluocinolone Acetonide—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00017	0.0193	CcSEcCtD
Fluocinolone Acetonide—Triamcinolone—NR3C1—metabolic syndrome X	0.00017	0.024	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	0.000164	0.00276	CbGpPWpGaD
Fluocinolone Acetonide—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000162	0.0183	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	0.00016	0.00269	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—NR1I3—metabolic syndrome X	0.000159	0.00267	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—PPARA—metabolic syndrome X	0.000158	0.00266	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—CD36—metabolic syndrome X	0.000157	0.00264	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	0.000155	0.00261	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	0.000154	0.00258	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—AGT—metabolic syndrome X	0.000153	0.00257	CbGpPWpGaD
Fluocinolone Acetonide—Fluticasone Propionate—NR3C1—metabolic syndrome X	0.000152	0.0214	CrCbGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—LEP—metabolic syndrome X	0.00015	0.00252	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—NR1I2—metabolic syndrome X	0.000145	0.00244	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—EDC4—metabolic syndrome X	0.000143	0.0024	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	0.000143	0.0024	CbGpPWpGaD
Fluocinolone Acetonide—Prednisolone—NR3C1—metabolic syndrome X	0.000142	0.02	CrCbGaD
Fluocinolone Acetonide—Betamethasone—NR3C1—metabolic syndrome X	0.000139	0.0196	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—APOA1—metabolic syndrome X	0.000137	0.00231	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—IRS1—metabolic syndrome X	0.000134	0.00225	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—AKT1—metabolic syndrome X	0.000134	0.00225	CbGpPWpGaD
Fluocinolone Acetonide—Pruritus—Metformin—metabolic syndrome X	0.000132	0.015	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Adipogenesis—PPARG—metabolic syndrome X	0.000131	0.0022	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Endothelins—AKT1—metabolic syndrome X	0.00013	0.00219	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	0.000129	0.00217	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—INS—metabolic syndrome X	0.000128	0.00215	CbGpPWpGaD
Fluocinolone Acetonide—Diarrhoea—Metformin—metabolic syndrome X	0.000128	0.0145	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	0.000127	0.00214	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	0.000127	0.00213	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—AKT1—metabolic syndrome X	0.000126	0.00211	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Endoderm Differentiation—TGFB1—metabolic syndrome X	0.000125	0.0021	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—FMO3—metabolic syndrome X	0.000124	0.00209	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—IGF1—metabolic syndrome X	0.000124	0.00208	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Metformin—metabolic syndrome X	0.000124	0.014	CcSEcCtD
Fluocinolone Acetonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—metabolic syndrome X	0.000123	0.00207	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	0.000123	0.00206	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—TGFB1—metabolic syndrome X	0.000122	0.00205	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Metformin—metabolic syndrome X	0.000119	0.0135	CcSEcCtD
Fluocinolone Acetonide—Rash—Metformin—metabolic syndrome X	0.000118	0.0134	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Metformin—metabolic syndrome X	0.000118	0.0133	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Adipogenesis—SERPINE1—metabolic syndrome X	0.000118	0.00198	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	0.000118	0.00198	CbGpPWpGaD
Fluocinolone Acetonide—Headache—Metformin—metabolic syndrome X	0.000117	0.0133	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—IGF1—metabolic syndrome X	0.000115	0.00193	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	0.000114	0.00192	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Metformin—metabolic syndrome X	0.000111	0.0126	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	0.000111	0.00187	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—MLXIPL—metabolic syndrome X	0.000111	0.00186	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—EPHX2—metabolic syndrome X	0.000111	0.00186	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—SERPINE1—metabolic syndrome X	0.000109	0.00183	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—ALB—metabolic syndrome X	0.000109	0.00183	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	0.000107	0.0018	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NR1H3—metabolic syndrome X	0.000104	0.00175	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—G6PC2—metabolic syndrome X	0.000104	0.00175	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	9.9e-05	0.00166	CbGpPWpGaD
Fluocinolone Acetonide—Triamcinolone—PTGS2—metabolic syndrome X	9.66e-05	0.0136	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	9.59e-05	0.00161	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—MTNR1B—metabolic syndrome X	9.24e-05	0.00155	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IGF2—metabolic syndrome X	9.2e-05	0.00155	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—IL6—metabolic syndrome X	9.19e-05	0.00155	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—APOB—metabolic syndrome X	8.94e-05	0.0015	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—FABP4—metabolic syndrome X	8.85e-05	0.00149	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HSD11B1—metabolic syndrome X	8.39e-05	0.00141	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	8.14e-05	0.00137	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—NR3C1—metabolic syndrome X	8.11e-05	0.0114	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CD36—metabolic syndrome X	8.11e-05	0.00136	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—metabolic syndrome X	8.1e-05	0.00136	CbGpPWpGaD
Fluocinolone Acetonide—Betamethasone—PTGS2—metabolic syndrome X	7.92e-05	0.0111	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	7.77e-05	0.00131	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	7.72e-05	0.0013	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NR1I3—metabolic syndrome X	7.64e-05	0.00128	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—metabolic syndrome X	7.55e-05	0.00127	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—G6PD—metabolic syndrome X	7.48e-05	0.00126	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—metabolic syndrome X	7.47e-05	0.00126	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—TGFB1—metabolic syndrome X	7.44e-05	0.00125	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	7.38e-05	0.00124	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HDAC3—metabolic syndrome X	7.3e-05	0.00123	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	7.21e-05	0.00121	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HTR2C—metabolic syndrome X	7.2e-05	0.00121	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LPA—metabolic syndrome X	7.14e-05	0.0012	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GCKR—metabolic syndrome X	7.14e-05	0.0012	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—APOA1—metabolic syndrome X	7.07e-05	0.00119	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NR1I2—metabolic syndrome X	6.98e-05	0.00117	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—TNF—metabolic syndrome X	6.94e-05	0.00117	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PLA2G6—metabolic syndrome X	6.91e-05	0.00116	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—metabolic syndrome X	6.87e-05	0.00116	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	6.86e-05	0.00115	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOA5—metabolic syndrome X	6.84e-05	0.00115	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GHRL—metabolic syndrome X	6.82e-05	0.00115	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	6.65e-05	0.00112	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	6.51e-05	0.00109	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CNR1—metabolic syndrome X	6.46e-05	0.00109	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	6.44e-05	0.00108	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—TRIB3—metabolic syndrome X	6.36e-05	0.00107	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HDAC3—metabolic syndrome X	6.1e-05	0.00103	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—TNF—metabolic syndrome X	6e-05	0.00101	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—IGF1—metabolic syndrome X	5.91e-05	0.000993	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—PPARA—metabolic syndrome X	5.78e-05	0.000971	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NAMPT—metabolic syndrome X	5.7e-05	0.000959	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	5.67e-05	0.000953	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GCK—metabolic syndrome X	5.67e-05	0.000953	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LIPC—metabolic syndrome X	5.67e-05	0.000953	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOC3—metabolic syndrome X	5.63e-05	0.000947	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SERPINE1—metabolic syndrome X	5.61e-05	0.000943	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—IL6—metabolic syndrome X	5.6e-05	0.000942	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—ALB—metabolic syndrome X	5.6e-05	0.000941	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CETP—metabolic syndrome X	5.47e-05	0.000919	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MTNR1B—metabolic syndrome X	5.46e-05	0.000917	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	5.37e-05	0.000902	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NOS3—metabolic syndrome X	5.36e-05	0.000901	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TRIB3—metabolic syndrome X	5.32e-05	0.000894	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RBP4—metabolic syndrome X	5.32e-05	0.000894	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SCARB1—metabolic syndrome X	5.24e-05	0.00088	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	5.1e-05	0.000857	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SREBF1—metabolic syndrome X	5.08e-05	0.000855	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCL5—metabolic syndrome X	5.01e-05	0.000842	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HMGCR—metabolic syndrome X	4.95e-05	0.000831	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GOT2—metabolic syndrome X	4.95e-05	0.000831	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL6—metabolic syndrome X	4.84e-05	0.000814	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	4.78e-05	0.000803	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—PPARG—metabolic syndrome X	4.77e-05	0.000802	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOC3—metabolic syndrome X	4.71e-05	0.000792	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—PTGS2—metabolic syndrome X	4.6e-05	0.00648	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	4.46e-05	0.00075	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCA1—metabolic syndrome X	4.41e-05	0.000741	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC2A4—metabolic syndrome X	4.41e-05	0.000741	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—SERPINE1—metabolic syndrome X	4.3e-05	0.000723	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GGT1—metabolic syndrome X	4.27e-05	0.000718	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GOT1—metabolic syndrome X	4.27e-05	0.000718	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HTR2C—metabolic syndrome X	4.25e-05	0.000715	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AGT—metabolic syndrome X	4.19e-05	0.000704	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CYBA—metabolic syndrome X	4.12e-05	0.000692	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GHRL—metabolic syndrome X	4.03e-05	0.000677	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CNR1—metabolic syndrome X	3.82e-05	0.000641	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOB—metabolic syndrome X	3.62e-05	0.000609	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TGFB1—metabolic syndrome X	3.54e-05	0.000595	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—LPL—metabolic syndrome X	3.46e-05	0.000581	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCL2—metabolic syndrome X	3.45e-05	0.00058	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SIRT1—metabolic syndrome X	3.35e-05	0.000562	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CD36—metabolic syndrome X	3.29e-05	0.000552	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF2—metabolic syndrome X	3.12e-05	0.000524	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPARA—metabolic syndrome X	3.06e-05	0.000514	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOB—metabolic syndrome X	3.03e-05	0.000509	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AGT—metabolic syndrome X	2.96e-05	0.000497	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCL5—metabolic syndrome X	2.96e-05	0.000497	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOE—metabolic syndrome X	2.9e-05	0.000487	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LPL—metabolic syndrome X	2.89e-05	0.000486	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOA1—metabolic syndrome X	2.87e-05	0.000482	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PPARA—metabolic syndrome X	2.78e-05	0.000467	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPARG—metabolic syndrome X	2.53e-05	0.000424	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—INS—metabolic syndrome X	2.48e-05	0.000416	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AGT—metabolic syndrome X	2.47e-05	0.000416	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—AKT1—metabolic syndrome X	2.46e-05	0.000414	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOE—metabolic syndrome X	2.42e-05	0.000408	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—LEP—metabolic syndrome X	2.42e-05	0.000408	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOA1—metabolic syndrome X	2.4e-05	0.000403	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PPARG—metabolic syndrome X	2.3e-05	0.000386	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALB—metabolic syndrome X	2.27e-05	0.000382	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NOS3—metabolic syndrome X	2.17e-05	0.000365	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IRS1—metabolic syndrome X	2.16e-05	0.000364	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—INS—metabolic syndrome X	2.07e-05	0.000348	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SERPINE1—metabolic syndrome X	2.07e-05	0.000348	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCL2—metabolic syndrome X	2.04e-05	0.000343	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IGF1—metabolic syndrome X	2e-05	0.000337	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGS2—metabolic syndrome X	1.99e-05	0.000334	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.9e-05	0.00032	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NOS3—metabolic syndrome X	1.82e-05	0.000305	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL6—metabolic syndrome X	1.53e-05	0.000258	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKT1—metabolic syndrome X	1.41e-05	0.000238	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TGFB1—metabolic syndrome X	1.2e-05	0.000202	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKT1—metabolic syndrome X	9.99e-06	0.000168	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—AKT1—metabolic syndrome X	9.09e-06	0.000153	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL6—metabolic syndrome X	9.05e-06	0.000152	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKT1—metabolic syndrome X	8.35e-06	0.00014	CbGpPWpGaD
